Protected Witnesses Found Guilty in Greece’s Novartis Trial
Two formerly protected witnesses at the center of Greece’s high-profile Novartis case were found guilty on Tuesday by…
Δίκη Novartis: Ενοχή και για τους δύο πρώην προστατευόμενους μάρτυρες
Με τη λέξη «ενοχή» σφράγισε την αγόρευση της η εισαγγελέας του Τριμελούς Πλημμελειοδικείου της Αθήνας ενώπιον του οποίου…
Switzerland’s Novartis buying San Diego biotech Avidity in $12 billion cash deal
Novartis staff celebrate the company’s 25 years in San Diego outside the Genomics Institute of the Novartis Research…
Glomerulonephritis Market Projected to Surge by 2034 with Rising Demand for Targeted Therapies
The glomerulonephritis market is witnessing steady growth driven by the increasing prevalence of chronic kidney diseases and improved…
Swiss drugmaker Novartis says it can withstand potential tariffs; TikTok deal reached as US and China seek to break trade deadlock
The CEO of Swiss pharmaceutical company Novartis said Saturday that it has enough stockpiles in the US to…
Swiss drugmaker Novartis says it can withstand potential tariffs; TikTok deal reached as US and China seek to break trade deadlock
The CEO of Swiss pharmaceutical company Novartis said Saturday that it has enough stockpiles in the US to…
Europe’s STOXX 600 slips as French rating review looms; still ends week higher
European shares ended the week on a strong note but were a little lower on Friday as investors…
Novartis to acquire Tourmaline Bio, complementing cardiovascular pipeline with pacibekitug for the treatment of atherosclerotic cardiovascular disease (ASCVD)
Tourmaline Bio is a clinical-stage biopharmaceutical company developing pacibekitug, an anti-IL-6 mAb, as a treatment option for…
Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease
Ad hoc announcement pursuant to Art. 53 LR NEPTUNUS-1 and NEPTUNUS-2 are the first ever global phase III…
Slovenija postaja farmacevtski center Evrope
V tokratni epizodi podkasta Tehnološki velikani gostimo dva moža, ki sta v samem središču preobrazbe, ki Slovenijo postavlja…
Novartis in Slovenia highlights (in)visible potentials on international day of persons with disabilities
Novartis in Slovenia raises awareness about the visible and invisible potentials of persons with disabilities on the International…
Novartis in Slovenia and the University of Ljubljana sign strategic cooperation agreement
Novartis LLC and the University of Ljubljana have signed a strategic cooperation agreement to further strengthen their partnership…